Literature DB >> 3056249

In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes.

H Tachibana1, E Yoshihara, Y Kaneda, T Nakae.   

Abstract

Cytolytic activity of liposomes consisting of stearylamine and phosphatidylcholine (SA/PC-liposomes) was examined in vitro against the bloodstream forms of Trypanosoma brucei gambiense. More than 99% of the cells (2 X 10(6)/ml) were killed within 30 min by treatment with 15 mol% SA/PC-liposomes (100 microM total lipids). As few as 1.2 X 10(12) liposomes per ml (equivalent to 2 nM liposome) showed trypanocidal activity. Fluorescence microscopy of cells treated with the dansylated SA/PC-liposomes suggested that the liposomes bound to and accumulated on the cell surface, eventually damaging the plasma membrane. SA/PC-liposomes showed no significant hemolysis when incubated with human and mouse erythrocytes under conditions that killed greater than 99.9% of the T. b. gambiense trypomastigotes. Human leukocytes were also shown to be less susceptible to SA/PC-liposomes than T. b. gambiense. These results may point to a new direction in strategy for therapy of African trypanosomiasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056249      PMCID: PMC172326          DOI: 10.1128/AAC.32.7.966

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Counting actively metabolizing tissue cultured cells.

Authors:  H J PHILLIPS; J E TERRYBERRY
Journal:  Exp Cell Res       Date:  1957-10       Impact factor: 3.905

2.  Antileishmanial activity of antimonials entrapped in liposomes.

Authors:  R R New; M L Chance; S C Thomas; W Peters
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

3.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

Authors:  C D Black; G J Watson; R J Ward
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

5.  Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.

Authors:  R R New; M L Chance
Journal:  Acta Trop       Date:  1980-09       Impact factor: 3.112

6.  Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.

Authors:  C R Alving; E A Steck; W L Hanson; P S Loizeaux; W L Chapman; V B Waits
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

Review 7.  Comparative properties and methods of preparation of lipid vesicles (liposomes).

Authors:  F Szoka; D Papahadjopoulos
Journal:  Annu Rev Biophys Bioeng       Date:  1980

8.  Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

9.  Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose.

Authors:  S M Lanham; D G Godfrey
Journal:  Exp Parasitol       Date:  1970-12       Impact factor: 2.011

10.  Surface charge of trypanosoma cruzi. Binding of cationized ferritin and measurement of cellular electrophoretic mobility.

Authors:  W De Souza; C Arguello; A Martinez-Paloma; D Trissl; A Gonzáles-Robles; E Chiari
Journal:  J Protozool       Date:  1977-08
View more
  5 in total

1.  Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.

Authors:  Roma Sinha; Jayeeta Roychoudhury; Partha Palit; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.

Authors:  O Kayser; C Olbrich; S L Croft; A F Kiderlen
Journal:  Parasitol Res       Date:  2002-12-11       Impact factor: 2.289

3.  Antileishmanial activities of stearylamine-bearing liposomes.

Authors:  T Dey; K Anam; F Afrin; N Ali
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  Antimicrobial activity of betaine esters, quaternary ammonium amphiphiles which spontaneously hydrolyze into nontoxic components.

Authors:  M Lindstedt; S Allenmark; R A Thompson; L Edebo
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

5.  Inhibition of the Growth of Plasmodium falciparum in Culture by Stearylamine-Phosphatidylcholine Liposomes.

Authors:  Gulam Mustafa Hasan; Neha Garg; Enna Dogra; Ranu Surolia; Prahlad Chandra Ghosh
Journal:  J Parasitol Res       Date:  2011-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.